Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin

Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin

US Patent 9550821 · Granted Jan 24, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of treating AML with PEGylated l-asparaginase2025
Pegylated L-asparaginase2023
Heparin-binding domain of IGFBP-2 in the treatment of metabolic disorders2021
PEGylated L-asparaginase2021
Compounds, compositions and uses thereof for improvement of bone disorders2021
PEGylated L-asparaginase2018
GH secretagogues and uses thereof2013
GH secretagogues and uses thereof2013
Unacylated ghrelin fragments as therapeutic agent in the treatment of obesity2012
GH secretagogues and uses thereof2012
Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders2012
Methods for promoting growth and survival of insulin-secreting cells2011